Financial Performance - Operating revenue for Q1 2023 was CNY 137,928,783.45, representing a year-on-year increase of 1.72%[9] - Net profit attributable to shareholders for Q1 2023 was CNY 11,205,873.56, down 4.66% from the same period last year[9] - Basic and diluted earnings per share for Q1 2023 were CNY 0.10, down from CNY 0.15 in Q1 2022, representing a decrease of 33.3%[53] - The company reported a total profit of CNY 12,711,449.75 for Q1 2023, compared to CNY 11,576,326.19 in Q1 2022, indicating an increase of about 9.8%[56] - The company's total comprehensive income for Q1 2023 was CNY 11,765,802.72, compared to CNY 10,433,833.27 in Q1 2022, showing an increase of approximately 12.8%[57] Cash Flow - Cash flow from operating activities for Q1 2023 increased by 271.49% to CNY 36,153,486.83 compared to CNY 9,732,133.76 in Q1 2022[10] - The company's cash and cash equivalents decreased to 112,973,135.35 yuan from 178,635,598.43 yuan, representing a decline of approximately 36.7%[43] - The company's investment activities resulted in a cash outflow of CNY 47,395,063.02 in Q1 2023, compared to CNY 2,494,801.08 in Q1 2022, reflecting a significant increase in investment spending[59] - The company’s financing activities led to a net cash outflow of CNY 42,716,706.26 in Q1 2023, contrasting with a net inflow of CNY 11,584,602.28 in Q1 2022[59] Assets and Liabilities - Total assets as of March 31, 2023, were CNY 687,291,036.35, a decrease of 5.55% compared to the end of the previous year[9] - The company’s total liabilities decreased to 221,467,305.72 yuan from 273,060,508.42 yuan, indicating a reduction of about 19%[45] - The company reported a total equity of 465,823,730.63 yuan as of March 31, 2023, compared to 454,617,857.07 yuan at the end of 2022, showing an increase of about 2.8%[45] - The total current assets were CNY 325,426,464.36, down from CNY 430,615,113.10, indicating a decrease of approximately 24.4%[49] Research and Development - Research and development expenses for Q1 2023 rose by 113.08% to CNY 5,316,149.80, indicating increased investment in innovation[16] - Research and development expenses rose significantly to CNY 5,316,149.80 in Q1 2023, compared to CNY 2,494,944.08 in Q1 2022, reflecting an increase of about 113.0%[52] Shareholder Information - The total number of unrestricted shares increased from 50,219,945 (46.25%) to 52,843,285 (48.66%) during the reporting period[24] - The total number of restricted shares decreased from 58,371,755 (53.75%) to 55,748,415 (51.34%)[24] - The total number of common shareholders at the end of the reporting period was 3,258[24] - The number of shareholders holding more than 5% of shares includes Guo Zhong with 32,672,300 shares (30.09%) and Kunming University with 6,110,000 shares (5.63%)[25][26] Other Financial Metrics - The company reported a credit impairment loss of CNY 1,242,442.28 in Q1 2023, compared to a reversal of CNY 302,793.16 in Q1 2022[52] - The company incurred financial expenses of CNY 1,199,415.66 in Q1 2023, compared to CNY 937,866.70 in Q1 2022, which is an increase of approximately 28%[56] - The company has pledged cash assets amounting to approximately 23.56 million yuan, which accounts for 3.43% of total assets[39] - The company has also pledged fixed assets valued at approximately 63.18 million yuan, representing 9.19% of total assets[39] Investment Activities - The company plans to dispose of its stake in a subsidiary in the Democratic Republic of the Congo, reclassifying it as held for sale[17] - The company has completed an acquisition project in Luliang County with a total investment of approximately 400 million yuan[37] - The company is investing in a new technology project in Yinchuan with an estimated annual output value of around 2.4 billion yuan[37]
昆工科技(831152) - 2023 Q1 - 季度财报